These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 25809253)
21. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization. Meng J; Shi C; Li L; Du Y; Xu Y Eur J Pharmacol; 2013 Oct; 718(1-3):87-97. PubMed ID: 24041920 [TBL] [Abstract][Full Text] [Related]
22. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin. Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396 [TBL] [Abstract][Full Text] [Related]
23. Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds. Hull CM; Genge CE; Hobbs Y; Rayani K; Lin E; Gunawan M; Shafaattalab S; Tibbits GF; Claydon TW Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R921-R931. PubMed ID: 31664867 [TBL] [Abstract][Full Text] [Related]
24. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484 [TBL] [Abstract][Full Text] [Related]
25. Molecular mapping of a site for Cd2+-induced modification of human ether-à-go-go-related gene (hERG) channel activation. Fernandez D; Ghanta A; Kinard KI; Sanguinetti MC J Physiol; 2005 Sep; 567(Pt 3):737-55. PubMed ID: 15975984 [TBL] [Abstract][Full Text] [Related]
26. Functional characterization of the LQT2-causing mutation R582C and the associated voltage-dependent fluorescence signal. Fougere RR; Es-Salah-Lamoureux Z; Rezazadeh S; Eldstrom J; Fedida D Heart Rhythm; 2011 Aug; 8(8):1273-80. PubMed ID: 21376840 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258 [TBL] [Abstract][Full Text] [Related]
29. Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2. Aidery P; Kisselbach J; Gaspar H; Baldea I; Schweizer PA; Becker R; Katus HA; Thomas D Biochem Biophys Res Commun; 2012 Feb; 418(4):830-5. PubMed ID: 22314138 [TBL] [Abstract][Full Text] [Related]
30. Sequence of gating charge movement and pore gating in HERG activation and deactivation pathways. Goodchild SJ; Macdonald LC; Fedida D Biophys J; 2015 Mar; 108(6):1435-1447. PubMed ID: 25809256 [TBL] [Abstract][Full Text] [Related]
31. Interactions between charged residues in the transmembrane segments of the voltage-sensing domain in the hERG channel. Zhang M; Liu J; Jiang M; Wu DM; Sonawane K; Guy HR; Tseng GN J Membr Biol; 2005 Oct; 207(3):169-81. PubMed ID: 16550488 [TBL] [Abstract][Full Text] [Related]
32. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. Perry M; Sachse FB; Sanguinetti MC Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551 [TBL] [Abstract][Full Text] [Related]
33. Frequency-dependent modulation of KCNQ1 and HERG1 potassium channels. Diness TG; Hansen RS; Olesen SP; Grunnet M Biochem Biophys Res Commun; 2006 May; 343(4):1224-33. PubMed ID: 16581021 [TBL] [Abstract][Full Text] [Related]
34. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator. Perry M; Sanguinetti MC Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604 [TBL] [Abstract][Full Text] [Related]
35. Blockade of HERG channels expressed in Xenopus oocytes by external H+. Jo SH; Youm JB; Kim I; Lee CO; Earm YE; Ho WK Pflugers Arch; 1999 Jun; 438(1):23-9. PubMed ID: 10370083 [TBL] [Abstract][Full Text] [Related]
36. Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration. Kim YJ; Hong HK; Lee HS; Moh SH; Park JC; Jo SH; Choe H J Cardiovasc Pharmacol; 2008 Dec; 52(6):485-93. PubMed ID: 19034039 [TBL] [Abstract][Full Text] [Related]
37. Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations. Subbotina J; Yarov-Yarovoy V; Lees-Miller J; Durdagi S; Guo J; Duff HJ; Noskov SY Proteins; 2010 Nov; 78(14):2922-34. PubMed ID: 20740484 [TBL] [Abstract][Full Text] [Related]
38. [The mechanistic rote of KCNH2 gene L413P and L559H mutations in long QT syndrome]. Li CL; Hu DY; Liu WL; Qi SY; Wang HT; Li L; Gong QM; Zhou ZF Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):838-41. PubMed ID: 18218237 [TBL] [Abstract][Full Text] [Related]
39. C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation. Gardner A; Sanguinetti MC Mol Pharmacol; 2015 Jul; 88(1):19-28. PubMed ID: 25888115 [TBL] [Abstract][Full Text] [Related]
40. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine. Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]